Immunotoxicity Considerations for Next Generation Cancer Nanomedicines

Although interest and funding in nanotechnology for oncological applications is thriving, translating these novel therapeutics through the earliest stages of preclinical assessment remains challenging. Upon intravenous administration, nanomaterials interact with constituents of the blood inducing a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hannon, Gary, Lysaght, Joanne, Liptrott, Neill J., Prina‐Mello, Adriele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6774033/
https://www.ncbi.nlm.nih.gov/pubmed/31592123
http://dx.doi.org/10.1002/advs.201900133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6774033/
https://www.ncbi.nlm.nih.gov/pubmed/31592123
http://dx.doi.org/10.1002/advs.201900133

Ejemplares similares